YB-1 is an early and central mediator of bacterial and sterile inflammation in vivo

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2604-2613

  Hanssen, Lydia ^a   Alidousty, Christina ^a   Djudjaj, Sonja ^a   Frye, Björn C ^a   Rauen, Thomas ^a   Boor, Peter ^a,b   Mertens, Peter R ^c   Van Roeyen, Claudia R ^a   Tacke, Frank ^a   Heymann, Felix ^a   Tittel, Andre P ^d   Koch, Alexander ^a   Floege, Jürgen ^a   Ostendorf, Tammo ^a   Raffetseder, Ute ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Faculty of Natural Sciences   (Slovakia)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; Y BOX BINDING PROTEIN 1;

ACUTE DISEASE; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL INFILTRATION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GRANULOCYTE; HUMAN; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; KIDNEY CELL; MALE; MORTALITY; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PYELONEPHRITIS; SURVIVAL RATE; UPREGULATION; URETER OBSTRUCTION; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEPHRITIS; PERITONITIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPSIS; TRANSCRIPTION FACTORS;

EID: 84883347059     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300416     Document Type: Article

References (39)

1. Akcay, A., Q. Nguyen, and C. L. Edelstein. 2009. Mediators of inflammation in acute kidney injury. Mediators Inflamm. 2009: 137072.
2. Mutsaers, S. E., J. E. Bishop, G. McGrouther, and G. J. Laurent. 1997. Mechanisms of tissue repair: from wound healing to fibrosis. Int. J. Biochem. Cell Biol. 29: 5-17.
3. Jahnukainen, T., M. Chen, and G. Celsi. 2005. Mechanisms of renal damage owing to infection. Pediatr. Nephrol. 20: 1043-1053.
4. Raffetseder, U., E. A. Liehn, C. Weber, and P. R. Mertens. 2012. Role of cold shock Y-box protein-1 in inflammation, atherosclerosis and organ transplant rejection. Eur. J. Cell Biol. 91: 567-575.
5. Diamond, P., M. F. Shannon, M. A. Vadas, and L. S. Coles. 2001. Cold shock domain factors activate the granulocyte-macrophage colony-stimulating factor promoter in stimulated Jurkat T cells. J. Biol. Chem. 276: 7943-7951.
6. Krohn, R., U. Raffetseder, I. Bot, A. Zernecke, E. Shagdarsuren, E. A. Liehn, P. J. van Santbrink, P. J. Nelson, E. A. Biessen, P. R. Mertens, and C. Weber. 2007. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice. Circulation 116: 1812-1820.
7. Basaki, Y., F. Hosoi, Y. Oda, A. Fotovati, Y. Maruyama, S. Oie, M. Ono, H. Izumi, K. Kohno, K. Sakai, et al. 2007. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene 26: 2736-2746.
8. Ohmori, M., H. Shimura, Y. Shimura, and L. D. Kohn. 1996. A Y-box protein is a suppressor factor that decreases thyrotropin receptor gene expression. Mol. Endocrinol. 10: 76-89.
9. Dhawan, L., B. Liu, A. Pytlak, S. Kulshrestha, B. C. Blaxall, and M. B. Taubman. 2012. Y-box binding protein 1 and RNase UK114 mediate monocyte chemoattractant protein 1 mRNA stability in vascular smooth muscle cells. Mol. Cell. Biol. 32: 3768-3775.
10. Jenkins, R. H., R. Bennagi, J. Martin, A. O. Phillips, J. E. Redman, and D. J. Fraser. 2010. A conserved stem loop motif in the 59 untranslated region regulates transforming growth factor-b(1) translation. PLoS One 5: e12283.
11. Raffetseder, U., B. Frye, T. Rauen, K. Jürchott, H. D. Royer, P. L. Jansen, and P. R. Mertens. 2003. Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection. J. Biol. Chem. 278: 18241-18248.
12. Frye, B. C., S. Halfter, S. Djudjaj, P. Muehlenberg, S. Weber, U. Raffetseder, A. En-Nia, H. Knott, J. M. Baron, S. Dooley, et al. 2009. Y-box protein-1 is actively secreted through a non-classical pathway and acts as an extracellular mitogen. EMBO Rep. 10: 783-789.
13. Raffetseder, U., T. Rauen, P. Boor, T. Ostendorf, L. Hanssen, J. Floege, A. En-Nia, S. Djudjaj, B. C. Frye, and P. R. Mertens. 2011. Extracellular YB-1 blockade in experimental nephritis upregulates Notch-3 receptor expression and signaling. Nephron, Exp. Nephrol. 118: e100-e108.
14. Raffetseder, U., N. Wernert, T. Ostendorf, C. van Roeyen, T. Rauen, P. Behrens, J. Floege, and P. R. Mertens. 2004. Mesangial cell expression of proto-oncogene Ets-1 during progression of mesangioproliferative glomerulonephritis. Kidney Int. 66: 622-632.
15. Rauen, T., U. Raffetseder, B. C. Frye, S. Djudjaj, P. J. Mühlenberg, F. Eitner, U. Lendahl, J. Bernhagen, S. Dooley, and P. R. Mertens. 2009. YB-1 acts as a ligand for Notch-3 receptors and modulates receptor activation. J. Biol. Chem. 284: 26928-26940.
16. Lu, Z. H., J. T. Books, and T. J. Ley. 2005. YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence. Mol. Cell. Biol. 25: 4625-4637.
17. Haberstroh, U., J. Pocock, C. Gómez-Guerrero, U. Helmchen, A. Hamann, J. C. Gutierrez-Ramos, R. A. Stahl, and F. Thaiss. 2002. Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells. Kidney Int. 62: 1264-1276.
18. Meyer-Schwesinger, C., S. Dehde, C. von Ruffer, S. Gatzemeier, P. Klug, U. O. Wenzel, R. A. Stahl, F. Thaiss, and T. N. Meyer. 2009. Rho kinase inhibition attenuates LPS-induced renal failure in mice in part by attenuation of NFkappaB p65 signaling. Am. J. Physiol. Renal Physiol. 296: F1088-F1099.
19. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. Schein, and W. J. Sibbald; The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644-1655.
20. Tittel, A. P., C. Heuser, C. Ohliger, C. Llanto, S. Yona, G. J. Hämmerling, D. R. Engel, N. Garbi, and C. Kurts. 2012. Functionally relevant neutrophilia in CD11c diphtheria toxin receptor transgenic mice. Nat. Methods 9: 385-390.
21. Raffetseder, U., T. Rauen, S. Djudjaj, M. Kretzler, A. En-Nia, F. Tacke, H. W. Zimmermann, P. J. Nelson, B. C. Frye, J. Floege, et al. 2009. Differential regulation of chemokine CCL5 expression in monocytes/macrophages and renal cells by Y-box protein-1. Kidney Int. 75: 185-196.
22. Boor, P., A. Konieczny, L. Villa, A. L. Schult, E. Bücher, S. Rong, U. Kunter, C. R. van Roeyen, T. Polakowski, H. Hawlisch, et al. 2007. Complement C5 mediates experimental tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 18: 1508-1515.
23. Hanssen, L., B. C. Frye, T. Ostendorf, C. Alidousty, S. Djudjaj, P. Boor, T. Rauen, J. Floege, P. R. Mertens, and U. Raffetseder. 2011. Y-box binding protein-1 mediates profibrotic effects of calcineurin inhibitors in the kidney. J. Immunol. 187: 298-308.
24. Panzer, U., O. M. Steinmetz, J. E. Turner, C. Meyer-Schwesinger, C. von Ruffer, T. N. Meyer, G. Zahner, C. Gómez-Guerrero, R. M. Schmid, U. Helmchen, et al. 2009. Resolution of renal inflammation: a new role for NF-kappaB1 (p50) in inflammatory kidney diseases. Am. J. Physiol. Renal Physiol. 297: F429-F439.
25. Roche, J. K., T. R. Keepers, L. K. Gross, R. M. Seaner, and T. G. Obrig. 2007. CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation. Am. J. Pathol. 170: 526-537.
26. Liverman, C. S., H. A. Kaftan, L. Cui, S. G. Hersperger, E. Taboada, R. M. Klein, and N. E. Berman. 2006. Altered expression of pro-inflammatory and developmental genes in the fetal brain in a mouse model of maternal infection. Neurosci. Lett. 399: 220-225.
27. Mertens, P. R., I. V. Martin, B. C. Frye, T. Rauen, S. Strauch, M. Pabst, and A. Geier. 2012. Rat Mrp2 gene expression is regulated by an interleukin-1bstimulated biphasic response with enhanced transcription and subcellular shuttling of YB-1. Eur. J. Cell Biol. 91: 533-541.
28. Silveira, C. G. T., J. Krampe, B. Ruhland, K. Diedrich, D. Hornung, and A. Agic. 2012. Cold-shock domain family member YB-1 expression in endometrium and endometriosis. Hum. Reprod. 27: 173-182.
29. Sutherland, B. W., J. Kucab, J. Wu, C. Lee, M. C. Cheang, E. Yorida, D. Turbin, S. Dedhar, C. Nelson, M. Pollak, et al. 2005. Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene 24: 4281-4292.
30. Wu, J., C. Lee, D. Yokom, H. Jiang, M. C. Cheang, E. Yorida, D. Turbin, I. M. Berquin, P. R. Mertens, T. Iftner, et al. 2006. Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2. Cancer Res. 66: 4872-4879.
31. Roger, T., C. Froidevaux, D. Le Roy, M. K. Reymond, A. L. Chanson, D. Mauri, K. Burns, B. M. Riederer, S. Akira, and T. Calandra. 2009. Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 106: 2348-2352.
32. Ness, T. L., K. J. Carpenter, J. L. Ewing, C. J. Gerard, C. M. Hogaboam, and S. L. Kunkel. 2004. CCR1 and CC chemokine ligand 5 interactions exacerbate innate immune responses during sepsis. J. Immunol. 173: 6938-6948.
33. McColl, S. R., and I. Clark-Lewis. 1999. Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists. J. Immunol. 163: 2829-2835.
34. Wolf, G., J. Bohlender, T. Bondeva, T. Roger, F. Thaiss, and U. O. Wenzel. 2006. Angiotensin II upregulates Toll-like receptor 4 on mesangial cells. J. Am. Soc. Nephrol. 17: 1585-1593.
35. Brown, H. J., H. R. Lock, T. G. Wolfs, W. A. Buurman, S. H. Sacks, and M. G. Robson. 2007. Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J. Am. Soc. Nephrol. 18: 1732-1739.
36. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
37. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
38. Nickel, W. 2003. The mystery of nonclassical protein secretion: a current view on cargo proteins and potential export routes. Eur. J. Biochem. 270: 2109-2119.
39. Andersson, U., and K. J. Tracey. 2011. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29: 139-162.